Multiple Sclerosis Trial, Recruiting (NCT07380022)

Multiple Sclerosis Trial, Recruiting NCT07380022 Sponsor: University of Thessaly Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07380022 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have Crohn's disease that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.
You have ulcerative colitis that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.
You have mildly elevated blood pressure (top number between 130–139 or bottom number between 80–89), you are managing it through lifestyle changes only (such as diet or exercise), you have no symptoms like headaches or dizziness, and you are not taking any blood pressure medication.
You are a woman with low iron levels shown by specific blood test results (confirm with trial site), or a man with low iron levels shown by specific blood test results (confirm with trial site), and your symptoms — such as tiredness, weakness, or dizziness — are mild and manageable, without serious complications.
You have multiple sclerosis that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You are currently taking antibiotics or have taken antibiotics within the past month.
You are currently taking any probiotic, prebiotic, or synbiotic supplements.
You are currently taking iron or zinc supplements.
Your type of medication (for any of the above conditions) has changed in the past three months.
The dose of your medication has changed in the past month.
You have a kidney or liver disease.
You are under 18 years of age, or you are unable to give your own informed consent to take part.
You do not have a sufficient understanding of the Greek language.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: ODYSSEAS ANDROUTSOS, School of Physical Education, Sport Science and Dietetics

Phone: +306989953903

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07380022

Sponsor: University of Thessaly

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +306989953903

More information: https://clinicaltrials.gov/study/NCT07380022

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have Crohn's disease that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.
You have ulcerative colitis that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.
You have mildly elevated blood pressure (top number between 130–139 or bottom number between 80–89), you are managing it through lifestyle changes only (such as diet or exercise), you have no symptoms like headaches or dizziness, and you are not taking any blood pressure medication.
You are a woman with low iron levels shown by specific blood test results (confirm with trial site), or a man with low iron levels shown by specific blood test results (confirm with trial site), and your symptoms — such as tiredness, weakness, or dizziness — are mild and manageable, without serious complications.
You have multiple sclerosis that is currently in remission, your type of medication has not changed in the past 3 months, and your dose has been the same for at least the past month.

Who may not be able to join:

You are currently pregnant or breastfeeding.
You are currently taking antibiotics or have taken antibiotics within the past month.
You are currently taking any probiotic, prebiotic, or synbiotic supplements.
You are currently taking iron or zinc supplements.
Your type of medication (for any of the above conditions) has changed in the past three months.
The dose of your medication has changed in the past month.
You have a kidney or liver disease.
You are under 18 years of age, or you are unable to give your own informed consent to take part.
You do not have a sufficient understanding of the Greek language.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Thessaly

Registry

ClinicalTrials.gov

Start date

9 July 2025

Est. completion

28 February 2026

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Acceptability of two dietary supplements containing microbial phytase, Goodphyte IB Defense and Goodphyte Immunity using an acceptability questionnaire; Adherence to the Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov